172 related articles for article (PubMed ID: 33571936)
1. IPG-based field potential measurement of cultured cardiomyocytes for optogenetic applications.
Wang TW; Sung YL; Chu HW; Lin SF
Biosens Bioelectron; 2021 May; 179():113060. PubMed ID: 33571936
[TBL] [Abstract][Full Text] [Related]
2. Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes.
Gruber A; Edri O; Huber I; Arbel G; Gepstein A; Shiti A; Shaheen N; Chorna S; Landesberg M; Gepstein L
JCI Insight; 2021 Jun; 6(11):. PubMed ID: 34100384
[TBL] [Abstract][Full Text] [Related]
3. Channelrhodopsins for Cell-Type Specific Illumination of Cardiac Electrophysiology.
Fernández MC; Kopton RA; Simon-Chica A; Madl J; Hilgendorf I; Zgierski-Johnston CM; Schneider-Warme F
Methods Mol Biol; 2021; 2191():287-307. PubMed ID: 32865751
[TBL] [Abstract][Full Text] [Related]
4. Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity.
Kopton RA; Buchmann C; Moss R; Kohl P; Peyronnet R; Schneider-Warme F
J Vis Exp; 2020 Mar; (157):. PubMed ID: 32202521
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Optogenetic Electrophysiology Tools in Human Stem Cell-Derived Cardiomyocytes.
Björk S; Ojala EA; Nordström T; Ahola A; Liljeström M; Hyttinen J; Kankuri E; Mervaala E
Front Physiol; 2017; 8():884. PubMed ID: 29163220
[TBL] [Abstract][Full Text] [Related]
6. Systemic gene transfer enables optogenetic pacing of mouse hearts.
Vogt CC; Bruegmann T; Malan D; Ottersbach A; Roell W; Fleischmann BK; Sasse P
Cardiovasc Res; 2015 May; 106(2):338-43. PubMed ID: 25587047
[TBL] [Abstract][Full Text] [Related]
7. Termination of re-entrant atrial tachycardia via optogenetic stimulation with optimized spatial targeting: insights from computational models.
Boyle PM; Murphy MJ; Karathanos TV; Zahid S; Blake RC; Trayanova NA
J Physiol; 2018 Jan; 596(2):181-196. PubMed ID: 29193078
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging.
Dempsey GT; Chaudhary KW; Atwater N; Nguyen C; Brown BS; McNeish JD; Cohen AE; Kralj JM
J Pharmacol Toxicol Methods; 2016; 81():240-50. PubMed ID: 27184445
[TBL] [Abstract][Full Text] [Related]
9. Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study.
Karathanos TV; Bayer JD; Wang D; Boyle PM; Trayanova NA
J Physiol; 2016 Dec; 594(23):6879-6891. PubMed ID: 26941055
[TBL] [Abstract][Full Text] [Related]
10. Portable low-cost macroscopic mapping system for all-optical cardiac electrophysiology.
Heinson YW; Han JL; Entcheva E
J Biomed Opt; 2023 Jan; 28(1):016001. PubMed ID: 36636698
[TBL] [Abstract][Full Text] [Related]
11. Ultra-low power deep sustained optogenetic excitation of human ventricular cardiomyocytes with red-shifted opsins: a computational study.
Pyari G; Bansal H; Roy S
J Physiol; 2022 Nov; 600(21):4653-4676. PubMed ID: 36068951
[TBL] [Abstract][Full Text] [Related]
12. Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes.
Bingen BO; Engels MC; Schalij MJ; Jangsangthong W; Neshati Z; Feola I; Ypey DL; Askar SF; Panfilov AV; Pijnappels DA; de Vries AA
Cardiovasc Res; 2014 Oct; 104(1):194-205. PubMed ID: 25082848
[TBL] [Abstract][Full Text] [Related]
13. Holographic optogenetic stimulation with calcium imaging as an all optical tool for cardiac electrophysiology.
Junge S; Schmieder F; Sasse P; Czarske J; Torres-Mapa ML; Heisterkamp A
J Biophotonics; 2022 Jul; 15(7):e202100352. PubMed ID: 35397155
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins.
Nussinovitch U; Shinnawi R; Gepstein L
Cardiovasc Res; 2014 Apr; 102(1):176-87. PubMed ID: 24518144
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Patel D; Stohlman J; Dang Q; Strauss DG; Blinova K
Toxicol Sci; 2019 Jul; 170(1):167-179. PubMed ID: 30912807
[TBL] [Abstract][Full Text] [Related]
16. Optical mapping of optogenetically shaped cardiac action potentials.
Park SA; Lee SR; Tung L; Yue DT
Sci Rep; 2014 Aug; 4():6125. PubMed ID: 25135113
[TBL] [Abstract][Full Text] [Related]
17. Optogenetic determination of the myocardial requirements for extrasystoles by cell type-specific targeting of ChannelRhodopsin-2.
Zaglia T; Pianca N; Borile G; Da Broi F; Richter C; Campione M; Lehnart SE; Luther S; Corrado D; Miquerol L; Mongillo M
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4495-504. PubMed ID: 26204914
[TBL] [Abstract][Full Text] [Related]
18. Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management.
Nyns ECA; Kip A; Bart CI; Plomp JJ; Zeppenfeld K; Schalij MJ; de Vries AAF; Pijnappels DA
Eur Heart J; 2017 Jul; 38(27):2132-2136. PubMed ID: 28011703
[TBL] [Abstract][Full Text] [Related]
19. Anion channelrhodopsins for inhibitory cardiac optogenetics.
Govorunova EG; Cunha SR; Sineshchekov OA; Spudich JL
Sci Rep; 2016 Sep; 6():33530. PubMed ID: 27628215
[TBL] [Abstract][Full Text] [Related]
20. Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model.
Williams JC; Xu J; Lu Z; Klimas A; Chen X; Ambrosi CM; Cohen IS; Entcheva E
PLoS Comput Biol; 2013; 9(9):e1003220. PubMed ID: 24068903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
